Sarah Boyce

CIK 1629383 · View on SEC EDGAR ↗

Insider

First SEC filing: June 11, 2020 · Latest: June 13, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 61 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

61 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 3, 2023 RNA S 10b5-1 3,221 $24.26 $78,141 53,352 Direct -5.69% Disposed
Feb. 2, 2023 RNA S 10b5-1 45,879 $24.36 $1,117,612 53,352 Direct -46.23% Disposed
Feb. 1, 2023 RNA S 10b5-1 900 $24.27 $21,843 53,352 Direct -1.66% Disposed
Nov. 10, 2022 OABIW P 15,000 $2.92 $43,800 36,000 Indirect +71.43% Acquired -92.4% (price as of 2026-08-20)
Nov. 9, 2022 OABIW P 21,000 $2.74 $57,540 21,000 Indirect — Acquired -91.9% (price as of 2026-08-20)
Aug. 25, 2022 RNA S 10b5-1 14,855 $23.07 $342,705 0 Direct -100.00% Disposed
Aug. 24, 2022 RNA S 10b5-1 35,045 $22.80 $799,026 0 Direct -100.00% Disposed
Aug. 15, 2022 RNA S 10b5-1 100 $22.47 $2,247 0 Direct -100.00% Disposed
Jan. 16, 2018 IONS S 2,196 $51.76 $113,665 8,931 Direct -19.74% Disposed 14.9% (price as of 2026-08-20)
Jan. 17, 2017 IONS S 506 $46.29 $23,423 5,252 Direct -8.79% Disposed 28.5% (price as of 2026-08-20)
Jan. 17, 2017 IONS S 855 $46.29 $39,578 4,463 Direct -16.08% Disposed 28.5% (price as of 2026-08-20)
Jan. 19, 2016 IONS S 872 $41.46 $36,153 1,735 Direct -33.45% Disposed 43.4% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 26, 2026 CTNM Stock Option (right to buy) Class A Common Stock (19,000) $14.19 June 25, 2036 19,000 Acquired
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (165,000) $31.42 Jan. 5, 2035 165,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (300,000) $10.16 Jan. 19, 2034 300,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (200,000) $6.57 Sept. 10, 2033 200,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (400,000) $22.47 Jan. 19, 2033 400,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (425,000) $14.22 Jan. 20, 2032 425,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (300,000) $22.34 Feb. 1, 2031 300,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (386,015) $1.24 Dec. 17, 2029 386,015 Disposed
Feb. 3, 2023 RNA Stock Option (Right to Common Stock (3,221) $1.24 Dec. 17, 2029 3,221 Disposed
Feb. 2, 2023 RNA Stock Option (Right to Buy) Common Stock (45,879) $1.24 Dec. 17, 2029 45,879 Disposed
Feb. 1, 2023 RNA Stock Option (Right to Buy) Common Stock (900) $1.24 Dec. 17, 2029 900 Disposed
Jan. 20, 2023 RNA Stock Option (Right to Buy) Common Stock (400,000) $22.47 Jan. 19, 2033 400,000 Acquired
Nov. 1, 2022 OABIW Stock Option Common Stock (37,840) $9.10 June 10, 2032 37,840 Acquired
Nov. 1, 2022 OABIW Stock Option Common Stock (13,994) $13.24 June 4, 2031 13,994 Acquired
Nov. 1, 2022 OABIW Stock Option Common Stock (10,565) $13.49 June 10, 2030 10,565 Acquired
Nov. 1, 2022 OABIW Stock Option Common Stock (22,616) $12.37 Oct. 15, 2029 22,616 Acquired
Nov. 1, 2022 LGND Employee Stock Option (right to buy) Common Stock (4,340) $90.68 June 10, 2032 4,340 Disposed
Aug. 25, 2022 RNA Stock Option (Right to Buy) Common Stock (14,855) $1.24 Dec. 17, 2029 14,855 Disposed
Aug. 24, 2022 RNA Stock Option (Right to Buy) Common Stock (35,045) $1.24 Dec. 17, 2029 35,045 Disposed
Aug. 15, 2022 RNA Stock Option (Right to Buy) Common Stock (100) $1.24 Dec. 17, 2029 100 Disposed
June 10, 2022 LGND Non-Qualified Stock Option (right to buy) Common Stock (4,340) $79.29 June 10, 2032 4,340 Acquired
Jan. 21, 2022 RNA Stock Option (Right to Buy) Common Stock (425,000) $14.22 Jan. 20, 2032 425,000 Acquired
June 4, 2021 LGND Non-Qualified Stock Option (right to buy) Common Stock (3,269) $115.39 June 4, 2031 3,269 Acquired
Feb. 2, 2021 RNA Stock Option (Right to Buy) Common Stock (300,000) $22.34 Feb. 1, 2031 300,000 Acquired
June 10, 2020 LGND Non-Qualified Stock Option (right to buy) Common Stock (2,468) $117.58 June 10, 2030 2,468 Acquired
Oct. 15, 2019 LGND Non-Qualified Stock Option (right to buy) Common Stock (5,283) $107.81 Oct. 15, 2029 5,283 Acquired
Jan. 15, 2018 IONS Restricted Stock Units Common Stock (5,367) — — 5,367 Disposed
Jan. 15, 2018 IONS Restricted Stock Units Common Stock (12,916) — — 12,916 Acquired
Jan. 2, 2018 IONS Employee Stock Option (right to buy) Common Stock (58,125) $49.25 Jan. 1, 2025 58,125 Acquired
Jan. 15, 2017 IONS Restricted Stock Units Common Stock (1,295) — — 1,295 Disposed
Jan. 15, 2017 IONS Restricted Stock Units Common Stock (2,188) — — 2,188 Disposed
Jan. 15, 2017 IONS Restricted Stock Units Common Stock (7,537) — — 7,537 Acquired
Jan. 3, 2017 IONS Employee Stock Option (right to buy) Common Stock (45,225) $47.34 Jan. 2, 2024 45,225 Acquired
Jan. 15, 2016 IONS Restricted Stock Units Common Stock (2,188) — — 2,188 Disposed
Jan. 15, 2016 IONS Restricted Stock Units Common Stock (5,178) — — 5,178 Acquired
Jan. 4, 2016 IONS Employee Stock Option (right to buy) Common Stock (31,070) $61.68 Jan. 3, 2023 31,070 Acquired
Jan. 15, 2015 IONS Restricted Stock Units Common Stock (8,750) — — 8,750 Acquired
Jan. 1, 2015 IONS Employee Stock Option (right to buy) Common Stock (52,500) $61.74 Dec. 31, 2021 52,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 11, 2020 RNA Stock Option (Right to Buy)→ Common Stock (1,197,015) 1,197,015 Direct
Jan. 5, 2015 IONS No Securities Owned 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CIK 1599901

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $659,900 — $10,748,480 $2,157,090 $594,000 — $17,010 $14,176,480
2023 $634,500 — $10,140,840 — $349,000 — $15,379 $11,139,719
2022 $601,400 — — — $430,100 — $15,336 $5,366,111

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.